Future Biosimilars: Upcoming Patent Expirations and Market Entry
Jan, 28 2026
Pharmacy and Drugs
Caspian Lockhart
Upcoming patent expirations for blockbuster biologics like Keytruda and Eylea will bring biosimilars to market, cutting drug costs by up to 35%. Learn how they work, when they’ll arrive, and why savings aren’t reaching patients yet.
